PDF Archive search engine
Last database update: 17 May at 11:24 - Around 76000 files indexed.

Show results per page

Results for «negotiation»:

Total: 700 results - 0.023 seconds

First Nations Oral Histories on Trial 99%

Regarding the treaty process, Woolford (2004) notes that not only are First Nations‟ governments constrained by inequalities, Canadian government officials present at the negotiation table are also limited by bureaucratization, which mandates what officials can discuss.


cupe.PDF 96%


EMBA (Evening) Syllabus MGT HSTU 96%

Managerial Communication and Negotiation 1.


Brexit Must Mean Exit. 04.05.17 95%

The supremacy of EU law will be largely preserved, and could result in the UK Government being forced to continue payments to the EU even after we have left.2 At the end of the negotiation process we will have had another three years of uncontrolled immigration from the EU (as from the date of the Referendum) and the White Paper provides no proposals for controlling immigration post-Brexit.


negotiationcreditcardscript 93%



RE Restructuring Consultant 21.10.2015 92%

Wir bieten We offer      Erstklassige Schulung und Einarbeitung Ein freundliches Team mit flachen Hierarchien Hervorragende Verdienstmöglichkeiten Flexible Arbeitszeitmodelle Interessante und komplexe Aufgaben      First-class schooling and on-the-job training A personable team with flat hierarchies An outstanding compensation package Flexible working hours Interesting and complex tasks Ihr Aufgabenbereich Your responsibilities Sie analysieren, bewerten und verhandeln Einzelhandelsmietverträge mit allen Akteuren You analyze, evaluate and negotiate Retail Real-Estate contracts with all involved stakeholders     Als Verhandlungsführer und Mediator lösen sie komplexe Problemsituationen Ihre Arbeit basiert auf einer fundierten Analyse der jeweiligen Immobilie, des Standortes und der Mietverträge Sie entwickeln Verhandlungsstrategien mit einem Fokus auf kreative win-win Lösungen Auf Ihrer Arbeit basiert das Portfolio Turnaround Management unserer Klienten Ihre Stärken        Empathie, intelligente Verhandlungsführung Hohe und verbindliche kommunikative Fähigkeiten am Telefon und in Person Sensible Überzeugungskraft und Kreativität Ein hohes Maß an Professionalität Abschlussstärke Ausgeprägte Teamfähigkeit, Flexibilität und Engagement Deutsch ist Ihre Muttersprache     As negotiation leader and mediator your task is to solve complex problem situations Your work is based on a detailed prior research of the individual Real Estate property, its location and rent contracts You are developing creative engagement strategies aiming at win-win solutions Your work is decisive for the portfolio turnaround management of our clients Your strengths       Empathy and a fundamental know-how of negotiations Outstanding communication skills (telephone and personally) A natural interest in negotiations and a talent to close deals successfully Professionality and decisiveness Excellent language skills (written and in speech) in Dutch, English and/or German Team spirit, flexibility and dedication


Acquisition Steps 92%



LLD Listing Guide pdf 91%

negotiation p. 4 stats, facts &


Short Sale Guide 89%

Negotiation of the Short Sale Once there is an offer on your property, we submit the offer and paperwork to the lender and negotiate the deal.


05112015 TPP - IP chapter complete 89%

    4 August 2015  FOR IMMEDIATE RELEASE  CONTACT: Zack Struver  +1 (202) 332­2670      Knowledge Ecology International Leaks TPP Text on Intellectual  Property    Tuesday, August 4th, 2015    Washington, DC — Today, August 4, 2015, Knowledge Ecology International (KEI) released  text from three sections of the 95­page secret negotiating text on the Intellectual Property  Chapter being used in the Trans­Pacific Partnership Agreement (TPP, sometimes referred to as  TPPA) trade negotiations. The negotiating text is dated May 11, 2015, and reflects the state of  the text right before the Maui rounds of the negotiation, which ended Friday, July 31, 2015.    Released this morning is text from the following sections of the IP Chapter:    ● All of Section B on Cooperation.  (Pages 8 to 10 of the IP Chapter)  ● All of Section E on “Patents / Undisclosed Test or Other Data / Traditional Knowledge.”  (Pages 29 to 53 of the IP Chapter)  ● Articles 1 through 11 from Section H on enforcement. (Pages 67 through 89 of the IP  Chapter)    We hope to release the remaining sections (A, C, D, F, G, and the rest of H) later today and  Wednesday.    The text will be placed on this web page:  ​­ip­text    The text released this morning is most relevant to issues related to pharmaceuticals, especially  rules on biologics and new chemicals. Later today or tomorrow, KEI will release sections of the  text relevant to copyright and trademarks.    KEI will publish a more detailed analysis of the text later. James Love, Director of Knowledge  Ecology International, released the following statement this morning:    “KEI is publishing the consolidated text for the TPP IP Chapter from May 11, 2015, in  order to enable the public to understand, analyze, and influence the rules that have been  proposed for intellectual property in this important trade negotiation.  Over 600 corporate  advisors already have access to this text, and this leak, at least temporarily, levels the  field somewhat (there will be a new text coming out of last week’s talks in Maui).    The May 11, 2015, text includes country positions, and reveals extensive disagreements  among parties, as well as the isolation of the United States as the country that continues  to be the most aggressive supporter of expanded intellectual property rights for drug  companies, publishers and other companies.    The proposals contained in the TPP will harm consumers and in some cases block  innovation. In countless ways, the Obama Administration has sought to expand and  extend drug monopolies and raise drug prices. The astonishing collection of proposals  page 1 of 4 pandering to big drug companies make more difficult the task of ensuring access to drugs  for the treatment of cancer and other diseases and conditions.    The widely reported dispute over the number of years of protection for biologic drug test  data is only one of dozens of measures that significantly expand the power of big drug  companies to charge high prices. Taken together these provisions will take the public  down a road of more and more rationing of medicines, and less and less equality of  access.  It could have and still can be different. Rather than focusing on more intellectual  property rights for drug companies, and a death­inducing spiral of higher prices and  access barriers, the trade agreement could seek new norms to expand the funding of  medical R&D as a public good, an area where the United States has an admirable track  record, such as the public funding of research at the NIH and other federal agencies.  Many people reading the provisions released today will appreciate how misguided and  wrong are the USTR’s values and negotiating objectives.”    James Love, Director, KEI, August 4, 2015    For more information and perspectives, we are also attaching the names and contact information  for several persons who can comment on the text released this morning, including health and  consumer group NGOs, academics, and industry experts.     Health and consumer group NGOs    Knowledge Ecology International  ● ● ● James Love, Director, +1.202.361.3040,  Andrew S. Goldman, Counsel for Policy & Legal Affairs, +1.202.332.2670,  Thiru Balasubramaniam, Geneva Representative,, +41 22 791 6727    Public Citizen  ● ● Peter Maybarduk, Director, +1.202.588.7755,  Burcu Kilic, Research Director, +1.202.588.7792,    Doctors Without Borders/Médecins Sans Frontières  ● Judit Rius Sanjuan, U.S. Manager & Legal Policy Adviser, Access Campaign, T:  +1.212.655.3762, M: +1.917.331.9077,     Academics    Professor Susan K. Sell  Elliott School of International Affairs  George Washington University  T: (202) 994­4896    Professor Kevin Outterson  Boston University School of Law    Dr. Deborah Gleeson  Department of Public Health  La Trobe University  Melbourne, Australia  T: +61 3 9479 3262  M: +61 423 209029    Professor Margot Kaminski  page 2 of 4 Moritz College of Law  Ohio State University    Professor Brook K. Baker  Program on Human Rights and the Global Economy  Northeastern University School of Law  T: (617) 373=3217  M: (617) 259­0760    Dr. Ruth Lopert  Department of Public Health  George Washington University  (202) 415­7726    Pharmaceutical and biotechnology industry experts who are familiar with the TPP IP  Chapter     Joseph Damond  Senior Vice President, International Affairs  Biotechnology Industry Organization (BIO)    Members of USTR’s Industry Trade Advisory Committees (ITAC)    ITAC 15: Industry Trade Advisory Committee on Intellectual Property Rights    Gregg H. Alton, Esq.  Executive Vice President, Corporate and Medical Affairs, Secretary and Chief Compliance Officer  Gilead Sciences, Inc.    Paul A. Coletti  Associate Patent Counsel  Johnson & Johnson    Erik H. Iverson, Esq.  President, Business and Operations  Infectious Disease Research Institute    Mr. Richard H. Kjeldgaard  Consultant  Representing Pharmaceutical Research and Manufacturers of America    Jeffrey P. Kushan, Esq.  Sidley Austin  Representing Biotechnology Industry Organization    Jonathan L. Marks, Esq.  Vice President, International Affairs  Generic Pharmaceuticals Association    ITAC 3: Industry Trade Advisory Committee On Chemicals, Pharmaceuticals,  Health/Science Products And Services    Ms. Tiffany McCullen Atwell  Director, International Government Affairs  DuPont Government Marketing and Government Affairs  E.I. du Pont de Nemours and Company  page 3 of 4   Mr. Harrison C. Cook  Vice President, International Government Affairs  Eli Lilly and Company    Mr. Ralph F. Ives  Executive Vice President, Global Strategy and Analysis  AdvaMed: Advanced Medical Technology Association     Mr. Maurice J. Kerins  President  Airmed Biotech, Inc.    Douglas T. Nelson, Esq.  Senior Advisor for Trade, Intellectual Property and Strategic Affairs  CropLife America    Mr. Paul A. Neureiter  Executive Director, Government Affairs  Amgen Inc.    Mr. James R. Plante  Founder and Chief Executive Officer  Pathway Genomics    Ms. Lisa M. Schroeter  Global Director, Trade and Investment Policy  The Dow Chemical Company   ###  page 4 of 4


Fire Lies 87%

Parity with PD is our #1 negotiation tool.


Oil Trader AOT EP1 86%

ASTRA TRANSCOR ENERGY trades in energy products worldwide.


sa template 85%

Whether you are buying your first home or looking to downsize after retirement, negotiation skills are crucial in getting what you want.


Clanki 85%


Resume 2017 84%

˗ Synthesis of permit application packages and all supporting documentation ˗ Preparation of emission calculation spreadsheets ˗ Negotiation with regulatory bodies on behalf of clients ˗ Demonstration of compliance with federal and state regulatory requirements ˗ Coordinating with internal staff to delegate work and meet deadlines  Maintained strong relationships with clients through consistent and effective communication  Improved event tracking and emissions calculation spreadsheets using visual basic macros and advanced spreadsheet techniques  Coordinated with clients and internal staff for regular site visits and sampling events Summer 2013 Process Intern, CH2M Hill  Designed utility system for fertilizer production facility as part of a design team  Responsible for successful design of cooling tower and basin for 132,000 gpm circulation cooling system including tower size, basin dimensions, pump placement, line sizing, etc.